Al­lergy drugs ‘out of stock’

Sunday Sun - - News -

CHIL­DREN with se­vere al­ler­gies face dif­fi­cul­ties with treat­ment as a pop­u­lar medicine has been de­clared “out of stock” amid an on­go­ing short­age.

EpiPen and EpiPen Ju­nior de­vices, supplied by My­lan and pro­duced by Pfizer, have faced short­ages in the UK and other coun­tries for months, but the Ju­nior ver­sion is now un­avail­able.

A state­ment is­sued to health­care providers on be­half of the De­part­ment of Health noted: “EpiPen and EpiPen Ju­nior will be sub­ject to lim­ited avail­abil­ity for the re­main­der of 2018.”

More of the Ju­nior de­vices are ex­pected in stock in Oc­to­ber, but it is not clear whether these will meet de­mand.

EpiPens are the most com­mon adren­a­line au­toin­jec­tor de­vices and are is­sued to peo­ple who suf­fer from se­ri­ous al­ler­gies. Users are be­ing ad­vised they can use their de­vices up to four months be­yond the listed ex­piry date.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.